Beta

AlvotechALVOW.US Overview

US StockHealthcare
(No presentation for ALVOW)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

ALVOW AI Insights

ALVOW Overall Performance

ALVOW AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

ALVOW Recent Performance

-

Alvotech

-1.10%

Avg of Sector

-0.49%

S&P500

ALVOW PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check ALVOW's Trend

ALVOW Key Information

ALVOW Valuation Metrics

ALVOW Profile

Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.

Price of ALVOW

ALVOW FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

ALVOW Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.09
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
59.82%
Net Margin
4.76%
Revenue Growth (YoY)
19.73%
Profit Growth (YoY)
15.24%
3-Year Revenue Growth
91.05%
3-Year Profit Growth
273.08%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.09
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
59.82%
Net Margin
4.76%
Revenue Growth (YoY)
19.73%
Profit Growth (YoY)
15.24%
3-Year Revenue Growth
91.05%
3-Year Profit Growth
273.08%
  • When is ALVOW's latest earnings report released?

    The most recent financial report for Alvotech (ALVOW) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ALVOW's short-term business performance and financial health. For the latest updates on ALVOW's earnings releases, visit this page regularly.

  • Where does ALVOW fall in the P/E River chart?

    According to historical valuation range analysis, Alvotech (ALVOW)'s current price-to-earnings (P/E) ratio is -3.3, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of ALVOW?

    According to the latest financial report, Alvotech (ALVOW) reported an Operating Profit of 48.21M with an Operating Margin of 28.98% this period, representing a growth of 257.86% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is ALVOW's revenue growth?

    In the latest financial report, Alvotech (ALVOW) announced revenue of 166.36M, with a Year-Over-Year growth rate of 10.03%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does ALVOW have?

    As of the end of the reporting period, Alvotech (ALVOW) had total debt of 1.45B, with a debt ratio of 0.97. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does ALVOW have?

    At the end of the period, Alvotech (ALVOW) held Total Cash and Cash Equivalents of 172.36M, accounting for 0.12 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does ALVOW go with three margins increasing?

    In the latest report, Alvotech (ALVOW) did not achieve the “three margins increasing” benchmark, with a gross margin of 63.18%%, operating margin of 28.98%%, and net margin of -65.27%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ALVOW's profit trajectory and future growth potential.

  • Is ALVOW's EPS continuing to grow?

    According to the past four quarterly reports, Alvotech (ALVOW)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.38. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of ALVOW?

    Alvotech (ALVOW)'s Free Cash Flow (FCF) for the period is -71.47M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 1.73% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of ALVOW?

    The latest valuation data shows Alvotech (ALVOW) has a Price-To-Earnings (PE) ratio of -3.3 and a Price/Earnings-To-Growth (PEG) ratio of -0. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.